Atlas Trials

Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma

Clinical trial NCT05270824 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05270824
Sponsor
Fujian Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Gastric CarcinomaCD8+ Tumor Infiltrating LymphocytesNeoadjuvant Immunotherapy
Start date
2022-03-01
Primary completion
2024-03-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.